ID: ALA323208

Max Phase: Preclinical

Molecular Formula: C17H16N2O3

Molecular Weight: 296.33

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(OC1C2CC3CC1N2CC3=O)c1c[nH]c2ccccc12

Standard InChI:  InChI=1S/C17H16N2O3/c20-15-8-19-13-5-9(15)6-14(19)16(13)22-17(21)11-7-18-12-4-2-1-3-10(11)12/h1-4,7,9,13-14,16,18H,5-6,8H2

Standard InChI Key:  OPCCXGXGEHABFP-UHFFFAOYSA-N

Associated Targets(Human)

Serotonin (5-HT) receptor 68 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 296.33Molecular Weight (Monoisotopic): 296.1161AlogP: 1.74#Rotatable Bonds: 2
Polar Surface Area: 62.40Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.18CX Basic pKa: 5.19CX LogP: 2.21CX LogD: 2.20
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.86Np Likeness Score: 0.57

References

1. Rival Y, Hoffmann R, Didier B, Rybaltchenko V, Bourguignon JJ, Wermuth CG..  (1998)  5-HT3 antagonists derived from aminopyridazine-type muscarinic M1 agonists.,  41  (3): [PMID:9464362] [10.1021/jm9705418]

Source